2000 NMT was founded by Prof. Jimmy Yun & Prof. Chen Jianfeng Listed in LUX Research as one of the top 7 private Asian nanotech company Started to use HGCP Technology for Pharmaceutical applications Established Pharmaceutical Division Opened its US$2.5-million new facility in Singapore Successfully developed pulmonary inhalable drug particles for anti-asthma, anti-diabetes and anti-migraine Licensed out HGCP Technology for manufacturing formulated cholesterol lowering drug to Beijing Winsunny HGCP Technology received Special Award at Nanotech Japan 2013 Signed clinical trial material supply contract with Christus Stehlin on CZ-48 anti-cancer drug Partnered with Micro-Sphere Switzerland to use its GMP manufacturing facility. Produced first batch of CZ-48 capsules Spin-off Pharmaceutical Division to establish NMT Pharmaceuticals Pte Ltd Signed LOI with CAO Pharmaceuticals on development & marketing right for CZ-48. 2004 2006 2008 2014 2013 2010 2015 2016 Signed Licensing Agreement with CAO Pharmaceuticals on exclusive worldwide development & marketing right for CZ-48 Started CZ-48 Clinical Trial Phase I in USA Acquired 100% by NMT Holding Invested in CAO Pharmaceuticals